Allergy & Immunology
Asthma is a chronic respiratory condition causing airway inflammation and narrowing. Advanced biologic infusion therapies help reduce flare-ups and improve breathing in severe or refractory cases.
Asthma is a chronic respiratory condition marked by inflammation and narrowing of the airways, making breathing difficult. It triggers episodes of wheezing, chest tightness, shortness of breath, and coughing. Severity varies — some individuals experience mild, occasional symptoms, while others face persistent or life-threatening flare-ups. Although there is no cure, targeted biologic therapies can significantly reduce symptoms and improve quality of life.
Seek medical advice if you experience ongoing shortness of breath, coughing or wheezing that doesn't improve with treatment, overuse of rescue inhalers, or nighttime symptoms that interrupt sleep. Seek emergency care for severe breathlessness, inability to speak, bluish lips, or no relief from a rescue inhaler.
Asthma arises from a mix of environmental and genetic factors. Common triggers include allergens, air pollutants, respiratory infections, exercise, cold air, and emotional stress. Occupational exposures to chemicals or dust may also contribute.
Biologic therapies target specific immune responses driving airway inflammation and are used in severe or refractory asthma. Risks include increased infection susceptibility and rare side effects from long-term steroid use including osteoporosis and hypertension. Infusion therapy enables clinically monitored administration for optimal respiratory outcomes.
Cinqair, Fasenra, Tezspire, Nucala, Xolair